News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
FDA Reform to Boost US Economy?
Dan Cossins | Mar 5, 2013
Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
Fears over Fast-Tracking Drugs
Edyta Zielinska | Sep 10, 2012
Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.
FDA Ups Recent Recalls
Bob Grant | Nov 9, 2011
The US regulatory agency recalled 54 percent more drugs from the second to third quarters of 2011.
Detecting New Synthetic Drugs
Cristina Luiggi | Sep 1, 2011
Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.
Opinion: Sustainable Drug Monitoring
Jur Strobos and Andy Stergachis | Aug 31, 2011
Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.